Status:
COMPLETED
Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
German Federal Ministry of Education and Research
Conditions:
Sarcoma, Ewing's
Eligibility:
All Genders
6-60 years
Brief Summary
The purpose of the study is to assess the functional outcome, quality of life and late sequelae in a representative sample of 600 long-term survivors of Ewing sarcoma and to build a unique clinical an...
Detailed Description
Trial objective: As survival rates of bone sarcoma patients have been raised owing to improved treatment strategies the focus of investigations is now on the medical, social, and economic sequelae of ...
Eligibility Criteria
Inclusion
- CESS81/CESS86/EICESS92/EURO-E.W.I.N.G.99 trials participants of the German Society of Pediatric Hematology and Oncology (GPOH)
Exclusion
- no complete remission (CR)
- any kind of paralysis
- \<3y after diagnosis
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
950 Patients enrolled
Trial Details
Trial ID
NCT00824083
Start Date
July 1 2009
End Date
July 1 2015
Last Update
April 28 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pediatric Hematology and Oncology, University Children's Hospital
Münster, North Rhine-Westphalia, Germany, 48129
2
Motion Analysis Lab, Orthopedic Department, University Hospital
Münster, North Rhine-Westphalia, Germany, 48129